Valiant Laboratories Ltd Quarterly Results

Gross Sales

46.2

46.82

57.79

35.23

21.48

Excise Duty

0

0

0

0

0

Net Sales

46.2

46.82

57.79

35.23

21.48

Other Operating Income

0

0

0

0

0

Other Income

0.87

0.66

-2.31

1.58

3.36

Total Income

47.07

47.48

55.47

36.81

24.84

Total Expenditure

46.12

44.42

53.96

34.61

28.22

PBIDT

0.94

3.05

1.51

2.2

-3.38

Interest

0.14

0.07

0.05

0.06

0.01

PBDT

0.81

2.98

1.46

2.14

-3.39

Depreciation

0.53

0.53

0.52

0.52

0.52

Minority Interest Before NP

0

0

0

0

0

Tax

0.03

0.59

-0.36

0.16

0.07

Deferred Tax

0.04

0.04

0.6

-0.88

0.76

Reported Profit After Tax

0.2

1.82

0.7

2.35

-4.74

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

0.2

1.82

0.7

2.35

-4.74

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

0.2

1.82

0.7

2.35

-4.74

EPS (Unit Curr.)

0.04

0.42

0.16

0.54

-1.09

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

43.45

43.45

43.45

43.45

43.45

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

2.03

6.51

2.61

6.24

-15.73

PBDTM(%)

1.75

6.36

2.52

6.07

-15.78

PATM(%)

0.43

3.88

1.21

6.67

-22.06